Ryan Sobel

TitleAssoc Professor
InstitutionThomas Jefferson University
DepartmentObstetrics-Gynecology
Address833 Chestnut Street
Philadelphia PA 19107
Phone215-503-6569
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. File B, Sobel R, Becker M, Nyirjesy P. Fluconazole-Resistant Candida Albicans Vaginal Infections at a Referral Center and Treated With Boric Acid. J Low Genit Tract Dis. 2023 Mar 24. PMID: 36961480.
      Citations:    
    2. Goje O, Sobel R, Nyirjesy P, Goldstein SR, Spitzer M, Faught B, Larson S, King T, Azie NE, Angulo D, Sobel JD. Oral Ibrexafungerp for Vulvovaginal Candidiasis Treatment: An Analysis of VANISH 303 and VANISH 306. J Womens Health (Larchmt). 2022 Oct 17. PMID: 36255448.
      Citations:    
    3. Schwebke JR, Sobel R, Gersten JK, Sussman SA, Lederman SN, Jacobs MA, Chappell BT, Weinstein DL, Moffett AH, Azie NE, Angulo DA, Harriott IA, Borroto-Esoda K, Ghannoum MA, Nyirjesy P, Sobel JD. Ibrexafungerp versus placebo for vulvovaginal candidiasis treatment: a phase 3, randomized, controlled superiority trial (VANISH 303). Clin Infect Dis. 2021 Sep 01. PMID: 34467969.
      Citations:    
    4. Sobel JD, Sobel R. Current and emerging pharmacotherapy for recurrent bacterial vaginosis. Expert Opin Pharmacother. 2021 Mar 29; 1-8. PMID: 33750246.
      Citations:    
    5. Story K, Sobel R. Fluconazole Prophylaxis in Prevention of Symptomatic Candida Vaginitis. Curr Infect Dis Rep. 2020 Jan 21; 22(1):2. PMID: 31965356.
      Citations:    
    6. Yano J, Sobel JD, Nyirjesy P, Sobel R, Williams VL, Yu Q, Noverr MC, Fidel PL. Current patient perspectives of vulvovaginal candidiasis: incidence, symptoms, management and post-treatment outcomes. BMC Womens Health. 2019 03 29; 19(1):48. PMID: 30925872.
      Citations:    
    7. Chavoustie SE, Eder SE, Koltun WD, Lemon TR, Mitchell C, Nyirjesy P, Sobel JD, Sobel R, Villanueva R. Experts explore the state of bacterial vaginosis and the unmet needs facing women and providers. Int J Gynaecol Obstet. 2017 05; 137(2):107-109. PMID: 28262922.
      Citations:    
    8. Sobel R, Sobel JD. Metronidazole for the treatment of vaginal infections. Expert Opin Pharmacother. 2015 May; 16(7):1109-15. PMID: 25887246.
      Citations:    
    Sobel's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (27)
    Explore
    _
    Co-Authors (1)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _